CS logo
small CS logo
Viome Life Sciences

Bothell, Washington, United States
Research institute in Bothell, Washington
11724 NE 195th St Suite 101, Bothell, WA 98011

About Viome Life Sciences


"As the research arm of Viome, VRI’s mission is to develop world-leading technology and make it available to the consumer and patient, so they can take control of their own health, increase healthspan, and live a great, worry-free life."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Viome
7
Total Rows: 1

Clinical Trials at Viome Life Sciences


During the past decade, Viome Life Sciences conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66110000Started TrialsCompleted Trails2022202302468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Longitudinal Analysis of the Vaginal Microbiome
2022-07-07
2023-06-01
Recruiting
10
Microbial and Human Determinants of the Onset of IBD Flares
2022-08-01
2025-07-01
Recruiting
2,000
Microbiome Determinants of Neurological and Gastrointestinal Symptoms of Autism Spectrum Disorder (ASD)
2022-05-14
2032-05-01
Recruiting
1,000
Viome Nutritional Programs to Improve Clinical Outcomes for Gastrointestinal Conditions
2022-11-18
2023-08-01
Recruiting
150
Viome Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions
2022-10-19
2023-06-01
Recruiting
150
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
2023-03-29
2024-03-01
Recruiting
150
Systems Biology of Gastrointestinal and Related Diseases
2022-12-01
2032-12-01
Not yet recruiting
100,000

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading SponsorsViome: 7Viome: 7

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Viome Life Sciences


According to Clinical.Site data, the most researched conditions in "Viome Life Sciences" are "Crohn Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Anxiety" (1 trials), "Autism Spectrum Disorder" (1 trials) and "Barrett Esophagus" (1 trials). Many other conditions were trialed in "Viome Life Sciences" in a lesser frequency.

Clinical Trials Intervention Types at Viome Life Sciences


Most popular intervention types in "Viome Life Sciences" are "Combination Product" (3 trials) and "Dietary Supplement" (3 trials). Other intervention types were less common.
The name of intervention was led by "VIOME Precision Nutrition Program" (3 trials) and "VIOME-designed condition-based supplements" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Viome Life Sciences


The vast majority of trials in "Viome Life Sciences" are 6 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Viome Life Sciences


Currently, there are NaN active trials in "Viome Life Sciences". 1 are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Viome Life Sciences, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Viome Life Sciences, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhaseNot Applicable: 3Not Applicable: 3

Created with Highcharts 11.1.0Trials StatusRecruiting: 6Recruiting: 6Not yet recruiting: 1Not yet recruiting: 1